# Hour 18 PSL Scores: 18:00-18:59

Released on 23 March 2026 | CEO Kevin Kawchak | ChemicalQDevice

## PSL Scores at End of Hour 18

| Robot Type | Dim A (Omniscient) | Dim B (Omnipresent) | Dim C (Omnipotent) | PSL | Delta | Band |
|-----------|-------------------|--------------------|--------------------|-----|-------|------|
| Surgical Robots | 7.2 | 5.8 | 7.5 | 6.8 | 0.0 | Advanced |
| Cobots | 7.0 | 6.5 | 6.2 | 6.6 | 0.0 | Advanced |
| RT Positioning | 7.5 | 6.0 | 6.8 | 6.8 | 0.0 | Advanced |
| Needle-Placement | 6.9 | 5.5 | 6.5 | 6.3 | 0.0 | Advanced |
| Social Companion | 5.5 | 7.2 | 4.0 | 5.6 | 0.0 | Intermediate |
| Humanoids | 5.8 | 6.0 | 5.2 | 5.7 | 0.0 | Intermediate |
| RT Motion-Tracking | 7.8 | 6.2 | 7.1 | 7.0 | +0.1 | Advanced |
| Imaging Assistant | 7.0 | 6.8 | 5.8 | 6.5 | 0.0 | Advanced |
| Steerable Needle | 7.2 | 5.2 | 7.0 | 6.5 | 0.0 | Advanced |
| Rehab Exoskeletons | 5.5 | 5.9 | 5.5 | 5.6 | 0.0 | Intermediate |

## Cumulative Site PSL: 65.4 + 0.1 = 65.5 (Advanced Site)

## Score Changes This Hour

### RT Motion-Tracking: Dim C +0.1 (7.0 to 7.1)
- Justification: Dual-vault evening operations with TRACK-02 (P0145, Vault 2)
  and TRACK-03 (P0151, Vault 3) running concurrent respiratory-gated VMAT
  sessions demonstrate expanded omnipotent capability. TRACK-02 delivered
  2.0 Gy with 94% gating efficiency and 0.8 mm tracking accuracy. TRACK-03
  initiated treatment with 0.9 mm tracking accuracy and stable gating. The
  simultaneous operation of two motion-tracking instances across separate
  vaults during evening peak volume validates the platform's capacity to
  deliver precision RT at scale without degradation of tracking accuracy or
  gating performance. This concurrent dual-vault mode represents a new
  operational capability level for the RT Motion-Tracking robot type.
- Regulatory basis: Per ICH E6(R3) Section 4.2.1, independent gating logs
  from both vaults were captured with synchronized UTC timestamps, confirming
  that concurrent operations did not introduce cross-system interference.
  Per 21 CFR Part 312.62, investigator records document dual-vault dose
  delivery accuracy within protocol-specified tolerances.

### No Changes: All Other Robot Types
- Surgical Robots: SURG-02 continues P0134 surgery. Ongoing procedure does
  not represent new capability; performance consistent with prior scoring.
- Cobots: COBOT-01 completed P0146 forearm biopsy with 1.1 mm accuracy.
  Performance consistent with established baseline; no uplift warranted.
- RT Positioning: RTPOS-03 completed P0147 mask fitting with 1.0 mm tolerance
  and 0.3 mm fiducial registration. Consistent with prior demonstrated
  capability. Standard meningioma protocol procedure.
- Needle-Placement: NEEDLE-02 completed P0149 parotid FNA with 1.0 mm
  accuracy, Grade A sample. Consistent with established parameters.
- Social Companion: COMPN-01 initiated P0153 session with anxiety score
  reduction from 6/10 to 4/10. Session ongoing; evaluation deferred to
  completion in Hour 19.
- Humanoids: HUMAN-03 provided P0148 pediatric coaching with 8.2/10
  engagement. Consistent with prior pediatric interaction scoring.
- Imaging Assistant: IMAGE-04 completed P0150 liver ultrasound with 8.1/10
  quality and 96% coverage. Consistent with established imaging parameters.
- Steerable Needle: STEER-01 initiated P0152 hepatic RFA. Procedure ongoing;
  evaluation deferred to completion in Hour 19.
- Rehab Exoskeletons: REHAB-03 completed P0148 pediatric gait training
  with 165 m distance and 0.68 symmetry. Consistent with prior
  rehabilitation session parameters.

## PSL Dimension Definitions

- Dimension A (Omniscient): Measures the robot's comprehensive data awareness,
  sensor fusion capability, AI model integration, and real-time clinical
  decision support. Higher scores indicate deeper integration of patient data,
  imaging, and predictive analytics.
- Dimension B (Omnipresent): Measures the robot's availability across time,
  space, and patient volume. Higher scores indicate broader temporal coverage,
  multi-instance deployment, and reduced access barriers.
- Dimension C (Omnipotent): Measures the robot's procedural capability range,
  precision, and clinical impact. Higher scores indicate broader therapeutic
  capability and higher precision in execution.

## USL Comparison Note

The USL framework (Kawchak, 2026; DOI: 10.5281/zenodo.18778220) evaluates
robot technical interoperability. Key USL scores for reference:

| Robot Platform | USL Score | PSL Score (this sim) |
|---------------|-----------|---------------------|
| da Vinci dVRK | 7.1 | 6.8 (Surgical) |
| Franka Panda | 7.4 | 6.6 (Cobot) |
| Boston Dynamics Atlas | 5.8 | 5.7 (Humanoid) |

The RT Motion-Tracking Dim C increase this hour reflects demonstrated
concurrent dual-vault operational capability during evening peak volume.
TRACK-02 and TRACK-03 independently maintained sub-millimeter tracking
accuracy while delivering respiratory-gated VMAT to two NSCLC patients
simultaneously. This concurrent precision under peak load extends the
omnipotent dimension beyond single-vault demonstrated capability, consistent
with the PSL framework's emphasis on demonstrated clinical performance
rather than static technical capability.

The single-patient cancer journey framework (Kawchak, 2026;
DOI: 10.5281/zenodo.19119939) documented RT delivery for an individual
patient pathway. Hour 18's dual-vault operations extend that paradigm to
concurrent multi-patient RT delivery within the on-demand trial context.
